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Basic Mechanisms of Ovarian Endocrine
Function
by David W. Schomberg*
This review outlines the current understanding ofovarian endocrine development and regulation with
both physiological and biochemical background to provide a framework applicable to problems concern-
ing environmental agents and ovarian endocrine function. Two approaches are used. First, the endocrine
regulation of foUicle development and corpus luteum function is considered in the classical sense, i.e.,
viewing these structures as gonadotropin-responsive units undergoing a programmed sequence of de-
velopment and differentiation. Secondly, a relatively new area of ovarian physiology concerned with
intra-ovarian regulation is explored, since this area holds potential for exploration ofthe direct effects of




The stages of follicular maturation have been
classified in a variety of ways by several different
investigators, depending upon the degree of detail
necessary (1, 2). For purposes of this discussion,
distinction need only be made between the follow-
ing: (1) the primordial follicle stage, characterized
by an immature ovum surrounded by a single layer
of flattened or disc-shaped granulosa cells; (2) the
primary follicle stage, characterized by a transition
in granulosa cell morphology to the cuboidal form
followed by an increase in the number ofgranulosa
cell layers (In the rat, oocyte growth is complete by
the four-layer granulosa cell stage); and (3) the an-
tral or vesicular follicle stage characterized by the
formation of a single fluid-filled antral cavity. After
formation of the antrum further follicular growth
occurs consisting mainly of enlargement of the fol-
licular cavity culminating in the preovulatory or
Graafian follicle.
Follicle development in most species, with the
notable exception ofthe human (3), is thought to be
independent of gonadotropic support up to the
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four-layergranulosacell stage ofthe primary follicle
(1). In the light of current knowledge, the acquisi-
tion by the follicle of a functional gonadotropin re-
ceptor population provides the distinction between
gonadotropin-dependent or -independent stages of
development. In the mouse, ovarian response to
follicle stimulating hormone (FSH) or luteinizing
hormone (LH) in terms of increased protein syn-
thesis and adenylyl cyclase activity, respectively, is
demonstrable during the second week oflife imply-
ing that functional gonadotropin receptors are pres-
ent at this early stage (4, 5). At 14 days of age,
mouse oocytes are surrounded by three or more
layers offollicle cells (4). In the rat, ovarian protein
kinase activity is responsive to FSH or LH at5 days
of age (6). In contrast, granulosa cells of the 24-
day-old immature rat have been reported to be de-
void of LH receptors (7) and do not respond to LH
in vitro with increased progesterone production (8).
At this time the predominant ovarian structures
consist of primary or pre-antral follicles. FSH and
LH levels in the rat decline between 15 and 24 days
of age (9), and presumably this leads, by
mechanisms not understood, to the disappearance
of the LH receptor population.
These circumstances in the rat have been turned
to remarkable advantage in the development of a
model system in which it has been possible to dem-
onstrate that the gonadotropin-dependent develop-
mental sequence of follicular development and
luteal formation has as its basis a time- and
endocrine-dependent progression of granulosa cell
June 1978 5receptors for FSH, LH, and prolactin (PRL). In an
important series of studies, Richards and Midgley
(10) and Richards et al. (11) demonstrated that ad-
ministration of estrogen and FSH to the 24-day-old
hypophysectomized rat leads to a marked increase
in the granulosa cell FSH receptor population; the
action ofestrogen and FSH in time also leads to the
appearance ofthe LH receptor population; the pro-
cess of luteinization subsequently leads to the ap-
pearance of the PRL receptor population. PRL is
also present in follicular fluid, but its role in
granulosa cell function is notunderstood atthis time
(12).
Cellular and Enzymatic Basis
of Steroid Secretion
Reproductive physiologists have long been in-
terested in determining the cellular origin of the
principal steroidal products of the ovary. Incuba-
tion studies with luteal and interstitial slices defini-
tively established that these compartments prefer-
entially synthesized progestin and androgen, re-
spectively, from labeled acetate (13). Similar tech-
niques were not applicable, however, to the fol-
licular compartment because ofthe close apposition
ofthecal and granulosa elements. The cellular basis
of follicular estrogen production has thus enjoyed
an interesting recent history beginning with the ex-
periments ofFalck in 1959 (14). He transplanted cell
types of various ovarian compartments, singly and
in certain combinations, to the anterior chamber of
the eye ofovariectomized rats. Using bits ofvaginal
epithelium placed alongside the ovarian cell trans-
plants as a biomarker, he obtained evidence of es-
trogen production only from combinations of
granulosa and thecal elements. The consensus of
subsequent studies with labeled precursors both in
vivo andin vitro is that the thecal cells possess all of
the requisite enzymatic assemblies necessary to
convert cholesterol to pregnenolone, progesterone,
testosterone, and estradiol. The granulosa cells, on
the other hand, are extremely deficient in "des-
molase," the enzyme function which results in the
conversion ofC21 to C,9 steroids; thus, they secrete
negligible quantities of androgen. They are well
equipped, however, to utilize androgen as a sub-
strate, forming estrogen via the "aromatase" sys-
tem. Moon et al. (15) and Dorrington et al. (16) have
contributed an important addition to these observa-
tions by demonstrating that conversion ofandrogen
to estrogen in the granulosa cell is under specific
regulation by FSH. This marks only the second es-
tablished gonadotropin-dependent rate-limiting
control point in sex steroid biosynthesis subsequent
to cholesterol formation, the first being the LH-
dependent 20a-hydroxylation ofcholesterol prior to
cholesterol conversion to pregnenolone (17). For a
comprehensive review of gonadal estrogen biosyn-
thesis, the reader is referred to the recent review by
Armstrong and Dorrington (18).
Endocrine Regulation of Corpus
Luteum Function
Since several reviews of the corpus luteum (CL)
including its cytology, biochemistry, and compara-
tive aspects in addition to its endocrine regulation
are available (19-23), only the general features of
luteal maintenance and regression will be discussed
here.
Luteotropic Control
In contrast to the relative uniformity in the endo-
crine control of follicular development and ovula-
tion, the processes of luteal maintenance and re-
gression show considerable species diversity. Al-
though the life span of the corpus luteum during
non-pregnant cycles varies considerably among
species, it is generally true that function is main-
tained by a low steady-state level of circulating
gonadotropin, LH in particular. LH is the pre-
dominant luteotropin in the nonpregnant woman
(24); LH and prolactin maximize luteal proges-
terone secretion in the sheep (25) and probably also
the rat (26); the hamster CL is dependent upon a
luteotropic complex consisting of FSH, LH, and
prolactin (27, 28). Even though serum LH and
steroid levels do not indicate a dynamic "push-
pull" relationship during the luteal phase, the con-
tinued presence ofLH or LH and PRL is necessary
for normal progesterone synthesis in both primates
(23, 24) and nonprimates (26, 29).
The question ofmaintenance is not a simple one,
however. Distinction has been made between dif-
ferent types of luteotropic activity based upon the
primary activity of the luteotropin, i.e., ster-
oidogenic vs. structural effects. LH has long been
known to stimulate steroidogenesis by luteal tissue
acutely orchronically, in vitro (13) orin vivo (30). It
is equally well known that prolactin is absolutely
critical for maintenance of the CL in the rat, for
example (30), but it is not steroidogenic in the acute
sense in vivo (31) or in vitro (32). Yet PRL may
somehow synergize with LH to maximize luteal
progesterone secretionin vivo (25). Thus, the extent
to which prolactin is luteotropic strictly in the
structural vs. the steroidogenic sense and the
mechanism(s) of its action are unclear (33). Some
Environmental Health Perspectivesstudies suggest its steroidogenic control might be
accomplished via regulation of the availability of
cholesterol stores (34).
The mechanism of LH action upon luteal
steroidogenesis has been actively investigated for
several years and has been the subject of several
authoritative reviews (13, 35-37). In common with
several other polypeptide hormones, its initial ac-
tion involves binding to a plasma membrane recep-
tor, activation ofadenylyl cyclase and generation of
intracellular cyclic AMP. The possible role ofcyclic
AMP and of cyclic AMP-dependent protein kinase
has been reviewed in depth very recently and is
highly recommended to the interested reader (38).
Briefly, evidence for the role of cyclic AMP action
in steroidogenesis is discussed in terms of several
intracellular control points: (1) cofactor availability,
(2) substrate availability, (3) cholesterol transport,
(4) cholesterol side-chain cleavage activity, and (5)
mitochondrial efflux of steroid substrate. The role
of protein synthesis in LH-stimulated steroidogen-
esis is also addressed. In addition to the model sys-
tems to be discussed later, it would seem that the in
vitro techniques utilized in the studies just men-
tioned would also be applicable to studies of the
mechanism(s) by which environmental agents influ-
ence gonadal steroidogenesis.
Luteolytic Control
In general, the CL ofthose species which exhibit
hysterectomy-induced prolongation also exhibit
prostaglandin F2a-induced luteolysis; furthermore,
luteal regression is accomplished experimentally in
the presence ofelevated LH or prolactin levels (39,
40). Therefore, the lytic stimulus in these species is
thought ofas being extrinsic to the ovary and func-
tionally dominant to steady-state tropic stimuli.
The mechanism(s) underlying prostaglandin-
induced luteolysis is incompletely understood at
this time. Detailed attention has been given for the
past several years to the suggestion by Pharriss (41)
that PGF2a-induced luteolysis resulted from se-
lective ovarian veno-constrictive action. Experi-
mental results have been divided. Studies in the ewe
by Niswender et al. (42) and Nett et al. (43) indicate
that PGF2a administration during the mid-luteal
phase ofthe cycle results in hemodynamic changes
in the ovary bearing the corpus luteum which are
similar to those seen during normal luteolysis. On
the other hand, several studies failed to support the
hypothesis: (1) mechanical reduction of blood flow
to the sheep ovary during the mid-luteal phase of
the cycle did not induce luteolysis (44); (2) experi-
ments in the rabbit indicated PGF2a did not consis-
tently change the vascular resistance ofthe corpora
lutea (45); and (3) PGF2a induced regression of cor-
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pora lutea transplanted to the rabbit kidney capsule,
thus ruling out the possibility of hemodynamic ef-
fects upon the ovarian vein (46). In spite of these
negative findings, however, the possible involve-
ment ofvascular mechanisms in luteolysis still can-
not be definitively excluded.
The biochemical mechanisms of luteolysis are
also only incompletely understood. Some of the
current studies which are germane to this area are:
the effects ofPGF2, upon LH receptor mechanisms
(47), the role of estrogen in prostaglandin-induced
luteolysis (48, 49) as well as the direct effects of
estradiol upon luteal cell progesterone secretion
(50), and the role of lysosomes in luteal regression
(51).
In those species in which hysterectomy does not
extend the luteal phase, notably the human and the
rhesus monkey (23, 52), evidence for prostaglan-
din-induced luteolysis is likewise meager (53). Con-
siderable uncertainty still exists in primates with re-
gard to the role ofprostaglandins in luteal function.
As examples, one need only cite observations such
as the following which are conceptually difficult to
relate at this point in time: (1) exogenous PGF2,,
does not induce luteolysis in the majority of cases
(53); (2) membrane preparations ofhuman luteal tis-
sue contain binding sites for prostaglandin F2a (54);
and (3) the ovary itself may produce sufficient
prostaglandin to saturate available receptor sites
(55, 56). Since evidence such as this cautions
against acceptance of the concept of a generalized
and dominant prostaglandin-induced lytic
mechanism, a more passive type of luteolytic con-
trol has been postulated, i.e., the withdrawal of
luteotropic support (57). Such a concept could in-
clude local cellular mechanisms which decreased
gonadotropin receptor number or function. It is
only fair to note, however, that such a mechanism
has not yet been demonstrated experimentally.
Intra-ovarian Regulation and the
Direct Study of Ovarian Endocrine
Cells
In addition to gonadotropic regulation of ovarian
endocrine function, studies in vitro with isolated
intact ovarian cells are re-emphasizing the possibil-
ity ofan additional level ofcontrol modulatedby the
ovarian steroids themselves. Studies with primary
cultures of ovarian granulosa cells have provided,
for example, direct demonstrations of the stimula-
tion of progesterone secretion by dihydrotestos-
terone (DHT) (Fig. 1) or DHT-FSH interactions
(58-60), and of estradiol suppression of proges-
terone secretion (58). The latter finding has also
been noted in isolated luteal cells (50).
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FIGURE 1. Dose-response relationship between dihydro-
testosterone and progestin secretion in porcine granulosa
cell monolayers: (0) progestin secretion during 2 days cul-
ture; (O) progestin secretion during 4 days culture. Bars rep-
resent + SEM. Each point represents the mean of four cul-
tures. From Schomberg et al. (58).
Intra-ovarian Regulation
The observations cited above are not the first
examples of intra-ovarian effects elicited by
steroids. In 1940, it was shown that either diethyl-
stilbestrol (DES) or estradiol-17/3 markedly
stimulated granulosa cell proliferation and also in-
creased ovarian responsiveness to gonadotropins in
the immature hypophysectomized rat (61, 62). The
effects of estrogen and progesterone upon ovum
maturation in vitro provide another possible exam-
ple(s) of steroid mediated intra-ovarian regulation
(63).
Nonsteroidal compounds are also part ofthe reg-
ulatory process at both the inter- and intracellular
levels. Since ovulation can be blocked in rabbits by
prostaglandin synthesis inhibitors such as in-
domethacin (64), prostaglandin action is thought to
be one of the components responsible for follicle
rupture. Other nonsteroidal compounds, as yet un-
identified, with the following activities and sites of
origin have been reported: a luteinization in-
hibitor(s) contained in follicular fluid (65), a
meiosis-inhibiting factor(s), also contained in fol-
licular fluid (66); and an inhibitor present in luteal
tissue which inhibits 1251-human chorionic gonado-
tropin binding (67). It goes without saying that the
potential capability for pinpointing the biochemical
effects of environmental agents increases signif-
icantly as new regulatory possibilities such as those
mentioned above become better understood.
Direct Study of Ovarian Cell Types
With the advent ofa variety oftechniques for cell
dispersion, cell separation, and in vitro culture, it is
now possible to study directly specific isolated
ovarian cell types. It is obvious that such an ap-
proach should not become an end in itself but
should contribute to a more comprehensive under-
standing ofovarian physiology in the broad sense of
the term. This goal depends in part, however, upon
a working knowledge of the various individual cel-
lular components. Since this aspect is in its infancy,
it will be reasonable to expect expanded efforts in
the study of isolated ovarian cell types at the basic
research level. The feasibility for application of
such systems to problems concerning the environ-
ment and reproduction remains to be determined
however. Their value to questions concerned with
biochemical mechanisms of action is obvious, but
the scope of usefulness may be broader than this.
For example, since granulosa cells are the only
other ovarian cell type sharing the follicular antral
compartment with the ovum and are readily studied
in vitro, is it possible that isolated granulosa cell
systems might serve a role in studies of the detec-
tion, metabolism, or detoxification of documented
or potential germ cell mutagens?
The author is indebted to discussions with Dr. J. McLachlan,
National Institute of Environmental Health Sciences, during
which he raised the possibility that studies of granulosa cells in
vitro may be germane to problems of germ cell mutagenesis.
REFERENCES
1. Greenwald, G. S. Role of follicle-stimulating hormone and
luteinizing hormone in follicular development and ovulation.
In: Handbook ofPhysiology, Section 7, Endocrinology, Vol.
IV, The Pituitary Gland, Part 2. R. 0. Greep, Ed., American
Physiological Society, Washington, D. C., 1974, p. 193.
2. Pedersen, T., and Peters, H. Proposal for a classification of
oocytes and follicles in the mouse ovary. J. Reprod. Fert. 17:
555 (1968).
3. Ross, G. T., et al. Pituitary gonadotropins and preantral fol-
licular maturation in women. In: Excerpta Medica Int.
Congr. Series No. 273. R. 0. Scow, Ed., Excerpta Medica.
Amsterdam, 1972, p. 903.
4. Lunenfeld, B., Kraiem, Z., and Eshkol, A. The function of
the growing follicle. J. Reprod. Fert. 45: 567 (1975).
5. Schneider, L. G., and Ben-Or, S. The effect of HMG and
FSH on amino acid incorporation in the developing ovary as
a function of age. In: The Development and Maturation of
the Ovary and Its Functions, Excerpta Medica, Int. Congr.
Series No. 267. H. Peters, Ed., Excerpta Medica, Amster-
dam, 1973, p. 38.
6. Deangelo, A. B., et al. Ovarian cyclic adenosine
monophosphate-dependent protein kinase activity: ontogeny
and effect ofgonadotropins. Endocrinology 97: 1509 (1975).
7. Erickson, G. F., Nimrod, A., and Ryan, K. J. Functional
FSH receptors in granulosa cells from preantral follicles:
Possible role in ovum maturation. J. Cell Biol. 67: p. 109a,
Abstract No. 218 (1975).
8 Environmental Health Perspectives8. Armstrong, D. T., and Dorrington, J. H. Androgens augment
FSH-induced progesterone secretion by cultured rat
granulosa cells. Endocrinology 99: 1411 (1976).
9. Dohler, K. D., and Wuttke, W. Se;tim LH, FSH, prolactin
and progesterone from birth to puberty in female and male
rats. Endocrinology 94: 1003 (1974).
10. Richards, J. S., and Midgley, A. R., Jr. Protein hormone
action: A key to understanding ovarian follicular and luteal
development. Biol. Reprod. 14: 82 (1976).
11. Richards, J. S., et al. Ovarian follicular development in the
rat. Hormone receptor regulation by estradiol, follicle
stimulating hormone and luteinizing hormone. Endocrinol-
ogy 99: 1562 (1976).
12. McNatty, K. P., Sawers, R. S., and McNeilly, A. S. A pos-
sible role for prolactin in control of steroid secretion by the
human Graafian follicle. Nature 250: 653 (1974).
13. Savard, K., Marsh, J. M., and Rice, B. F. Gonadotropins
and ovarian steroidogenesis. Rec. Progr. Hormone Res. 21:
285 (1965).
14. Falck, B. Site of production of oestrogen in rat ovary as
studied in micro-transplants. Acta Physiol. Scand. (Suppl.
163) 47: 1 (1959).
15. Moon, Y. S., Dorrington, J. H., and Armstrong, D. T.
Stimulatory action of follicle-stimulating hormone on
estradiol-17/3 secretion by hypophysectomized rat ovaries in
organ culture. Endocrinology 97: 244 (1975).
16. Dorrington, J. A., Moon, Y. S., and Armstrong, D. T.
Estradiol-17,8 biosynthesis in cultured granulosa cells from
hypophysectomized immature rats: Stimulation by follicle-
stimulating hormone. Endocrinology 97: 1328 (1975).
17. Hall, P. F., and Young, D. G. Site of action of trophic hor-
mones upon the biosynthetic pathways to steroid hormones.
Endocrinology 82: 559 (1968).
18. Armstrong, D. T., and Dorrington, J. H. Estrogen biosyn-
thesis in the ovaries and testes. In: Regulatory Mechanisms
Affecting Gonadal Hormone Action, Advances in Sex Hor-
mone Research. Vol. 3, J. A. Thomas and R. L. Singhal,
Eds., University Park Press, Baltimore, 1977, p. 217.
19. Enders, A. C. Cytology ofthe corpus luteum. Biol. Reprod.
8: 158 (1973).
20. Savard, K. The biochemistry of the corpus luteum. Biol.
Reprod. 8: 183 (1973).
21. Hilliard, J. Corpus luteum function in guinea pigs, hamsters,
rats, mice, and rabbits. Biol. Reprod. 8: 203 (1973).
22. Hansel, W., Concannon, P. W., and Lukaszewska, J. H.
Corpora luteaofthe large domestic animals. Biol. Reprod. 8:
222 (1973).
23. Knobil, E. On the regulation of the primate corpus luteum.
Biol. Reprod. 8: 246 (1973).
24. Vande Wiele, R. L., et al. Mechanisms regulating the
menstrual cycle in women. Rec. Prog. Hormone Res. 26: 63
(1970).
25. Denamur, R., Martinet, J., and Short, R. V. Pituitary control
ofthe ovine corpus luteum. J. Reprod. Fert. 32: 207 (1973).
26. Shaikh, A. A., and Gilmore, D. P. Factors involved in the
maintenance of luteal function in the pseudopregnant rat. J.
Reprod. Fert. 36: 387 (1974).
27. Greenwald, G. S. Prolactin and FSH constitute a minimal
luteotropic complex in the hamster. Endocrinology 80: 118
(1967).
28. Jaggannadha, R. A., Madhwa Raj, H. G., and Mougdal,
N. R. Need ofLHforearly pregnancy in thegolden hamster.
J. Reprod. Fert. 23: 353 (1970).
29. Denamur, R., Martinet, J., and Short, R. V. Secretion de la
progesterone par les corps jaunes de la brebis apres
hypophysectomie, section de la tige pituitaire et hysterec-
tomie. Acta Endocrinol. 52: 72 (1966).
30. McCracken, J. A., Baird, D. T., and Goding, J. R. Factors
affecting the secretion of steroids from the transplanted
ovary inthe sheep. Rec. Prog. Hormone Res. 27: 537 (1971).
31. Astwood, E. B. The regulation ofcorpus luteum function by
hypophyseal luteotropin. Endocrinology 28: 309 (1941).
32. Yoshinaga, K., Grieves, S. A., and Short, R. V.
Steroidogenic effects of luteinizing hormone and prolactin
on the rat ovary in vivo. J. Endocrinol. 38: 423 (1967).
33. Marsh, J. M., Telegdy, G., and Savard, K. Effect of
gonadotropins on steroidogenesis in rat ovaries at diestrus.
Nature 212: 950 (1966).
34. Hilliard, J., et al. Effect ofprolactin on progestin release and
cholesterol storage by rabbit ovarian interstitium. Endo-
crinology 82: 122 (1968).
35. Armstrong, D. T. Hormones and reproduction. Gonadotro-
pins, ovarian metabolism and steroid biosynthesis. Rec.
Prog. Hormone Res. 24: 255 (1968).
36. Marsh, J. M., and Savard, K. Studies on the mode ofaction
of luteinizing hormone on steroidogenesis in the corpus
luteumin vitro. J. Reprod. Fert. Suppl. 1: 113 (1966).
37. Marsh, J. M. The role ofadenosine 3', 5'-monophosphate in
the action of luteinizing hormone on steroidogenesis. In:
Progress in Endocrinology. C. Gaul and F.J.B. Ebling, Eds.,
Excerpta Medica Foundation, Amsterdam, The Nether-
lands, 1969, p. 83.
38. Marsh, J. M. The role of cyclic AMP in gonadal steroido-
genesis. Biol. Reprod. 14: 30 (1976).
39. Cerini, M. E., et al. Luteolysis in sheep with ovarian auto-
transplants following concurrent infusions of luteinizing
hormone and prostaglandin F2a, into the ovarian artery.
Prostaglandins 3: 399 (1972).
40. Chamley, W. A., Cerini, J. C., and Goding, J. R. Luteal
function in sheep with ovarian autotransplants given concur-
rent infusions ofprolactin and prostaglandin F20into the ova-
rian artery. Prostaglandins 4: 711 (1973).
41. Pharriss, B. B. The possible vascular regulation of luteal
function. Perspect. Biol. Med. 13: 434 (1970).
42. Niswender, G. D., Diekman, M. A., and Nett, T. M. Blood
flow: A mediator of ovarian function. Biol. Reprod. 14: 64
(1976).
43. Nett, T. M., McClellan, M. C., and Niswender, G. D. Ef-
fects of prostaglandins on the ovine corpus luteum: Blood
flow, secretion of progesterone and morphology. Biol. Re-
prod. 15: 66 (1976).
44. Moore, R. T., and D'Alecy, L. G. Functional relationship
between ovarian blood flow and luteal regression in the ewe.
Proc. 9th Ann. Meet. Soc. for Study of Reproduction,
Philadelphia, Pa., 1976, Abstr. No. 51.
45. Janson, P. O., Albrecht, I., and Ahren, K. Effects of pros-
taglandin F2aon ovarian blood flow and vascular resistance
in the pseudopregnant rabbit. Acta Endocrinol. 79: 337
(1975).
46. Keyes, P. L., and Bullock, D. W. Effects of prostaglandin
F2a on ectopic and ovarian corpora lutea ofthe rabbit. Biol.
Reprod. 10: 519 (1974).
47. Grinwich, D. L., Hitchens, M., and Behrman, H. R. Control
ofthe LH receptor by prolactin and prostaglandin F2 in rat
corpora lutea. Biol. Reprod. 14: 212 (1976).
48. Shaikh, A., and Klaiber, E. L. Effects of sequential treat-
ment with estradiol and PGF2a,on the length of the primate
menstrual cycle. Prostaglandins 6: 253 (1974).
49. Gengenbach, D. R., Hixon, J. E., and Hansel, W. A luteoly-
tic interaction between estradiol and prostaglandin F2,', in
hysterectomized ewes. Biol. Reprod. 16: 571 (1977).
50. Stouffer, R. L., Nixon, W. E., and Hodgen, G. D. Estrogen
inhibition of basal and gonadotropin-stimulated proges-
terone production by rhesus monkey luteal cells in vitro.
Endocrinology 101: 1157 (1977).
51. McClellan, M. C., Abel, J. H., and Niswender, G. D. Func-
June 1978 9tion of lysosomes during luteal regression in normally cycl-
ing and PGF2a -treated ewes. Biol. Reprod. 16: 499 (1977).
52. Marcus, S. L. Luteal function following hysterectomy. In:
The Regulation ofMammalian Reproduction. S. J. Segal, et
al., Eds., C. C Thomas, Springfi'eld, Ill., 1973, p. 471.
53. Goldberg, V. J., and Ramweli, P. W. Role ofprostaglandins
in reproduction. Physiol. Revs. 55: 325 (1975).
54. Rao, Ch. V., Griffin, L. P., and Carman, F. R., Jr. Prosta-
glandin F2a binding sites in human corpora lutea. J. Clin.
Endrocrinol. Metab. 44: 1032 (1977).
55. Wilks, J. W., Forbes, K. K., and Norland, J. F. Synthesis of
prostaglandin F2aby the ovary and uterus. J. Reprod. Med.
9: 271 (1972). '
56. Powell, W. S., et al. Prostaglandin F2y receptor in human
corpora lutea. Lancet 1: 1120 (1974).
57. Schomberg, D. W. The regulation of luteal regression. In:
The Regulation ofMammalian Reproduction. S. S. Segal, et
al., Eds., C. C Thomas, Springfield, Ill., 1973, p. 462.
58. Schomberg, D. W., Stouffer, R. L., and Tyrey, L. Modula-
tion of progestin secretion in ovarian cells by 17/3-hy-
droxy-Sa-androstan-3-one (dihydrotestosterone): a direct
demonstration in monolayer culture. Biochem. Biophys.
Res. Commun. 68: 77 (1976).
59. Lucky, A., et al. Progesterone production by cultured
preantral rat granulosa cells: stimulation by androgens.
Endrocrinology 100: 128 (1977).
60. Armstrong, D. T., and Dorrington, J. H. Androgens augment
FSH-induced progesterone secretion by cultured rat
granulosa cells. Endocrinology 99: 1141 (1976).
61. Pencharz, R. I. Effect ofestrogens and androgens alone and
in combination with chorionic gonadotropin on the ovary of
the hypophysectomized rat. Science 91: 554 (1940).
62. Williams, P. C. Effect of stilbestrol on the ovaries of
hypophysectomized rats. Nature 145: 388 (1940).
63. McGaughey, R. W. The culture of pig oocytes in minimal
medium, and the influence ofprogesterone and estradiol-17,8
on meiotic maturation. Endocrinology 100: 39 (1977).
64. Grinwich, D. L., Kennedy, T. G., and Armstrong, D. T.
Dissociation of ovulatory and steroidogenic actions of
luteinizing hormone in rabbits with indomethacin, an in-
hibitor of prostaglandin synthesis. Prostaglandins 1: 89
(1972).
65. Ledwitz-Rigby, F., et al. Inhibitory action of porcine fol-
licular fluid upon granulosa cell luteinization in vitro: assay
and influence offollicular maturation. J. Endocrinol. 74: 175
(1977).
66. Tsafriri, A., Pomerantz, S. H., and Channing, C. P. Inhibi-
tion of oocyte maturation by porcine follicular fluid: Partial
characterizationoftheinhibitor. Biol. Reprod. 14: 511 (1976).
(1976).
67. Yang, K., Samaan, N. A., and Ward, D. N. Characterization
ofan inhibitor for luteinizing hormone receptor site binding.
Endocrinology 98: 233 (1976).
10 Environmental Health Perspectives